Procalcitonin as an early marker of bacterial infection in neutropenic febrile children with acute lymphoblastic leukemia

Inflammation Research

Volumn 59, Issue 5, 2010, Pages 339-347

  Hatzistilianou, Maria ^a   Rekliti, Aleka ^a   Athanassiadou, Fanni ^a   Catriu, Dorothea ^a  

^a ARISTOTLE UNIVERSITY OF THESSALONIKI   (Greece)

Author keywords

ALL; Children; CRP; Cytokines; IL 1b; IL 8; PCT; STNFRII

Indexed keywords

BIOLOGICAL MARKER; C REACTIVE PROTEIN; INTERLEUKIN 1BETA; INTERLEUKIN 8; PROCALCITONIN; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR RECEPTOR 2;

ACUTE LYMPHOBLASTIC LEUKEMIA; ADOLESCENT; ARTICLE; BACTERIAL INFECTION; CHILD; CONTROLLED STUDY; DIFFERENTIAL DIAGNOSIS; EARLY DIAGNOSIS; FEBRILE NEUTROPENIA; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRESCHOOL CHILD; PROTEIN BLOOD LEVEL; SCHOOL CHILD; SENSITIVITY AND SPECIFICITY; VIRUS INFECTION;

ADOLESCENT; BACTERIAL INFECTIONS; BIOLOGICAL MARKERS; C-REACTIVE PROTEIN; CALCITONIN; CHILD; CHILD, PRESCHOOL; FEVER; HUMANS; INFANT; INTERLEUKIN-1BETA; INTERLEUKIN-8; NEUTROPENIA; PRECURSOR CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA; PROTEIN PRECURSORS; RECEPTORS, TUMOR NECROSIS FACTOR, TYPE II; ROC CURVE; TUMOR NECROSIS FACTOR-ALPHA;

EID: 77953356360     PISSN: 10233830     EISSN: 1420908X     Source Type: Journal    
DOI: 10.1007/s00011-009-0100-0     Document Type: Article

References (32)

1. Finberg RW, Talcott JA. Fever and neutropenia-how to use a new treatment strategy. N Engl J Med. 1999;341(5):362-368
2. Crokaert F. Febrile neutropenia in children. Int J Antimicrob Agent. 2000;16:173-177
3. Schimpff SC. Infections in the cancer patients-diagnosis, prevention and treatment. In: Mandell GL, Douglas RG, Bennet JE, editors. Principles and practice of infectious diseases. New York: Churchill Livingstone; 1995. p. 2666.
4. Laws HJ, Schneider DT, Janssen G, Wessalowski R, Dilloo D, Meisel R, et al. Trends in infections in children with malignant disease in 2000: comparison of data of 1980/81. Pediatr Hematol Oncol. 2000;24(5):343-354
5. Von Lilienfeld-Toal M, Dietrich MP, Glasmacher A, Lehmann L, Breig P, Hahn C, et al. Markers of bacteremia in febrile neutro-penic patients with hematological malignancies: procalcitonin and IL-6 are more reliable than C-reactive protein. Eur J Clin Macrobiol Infect Dis. 2004;23:539-544
6. Hitoglou S, Hatzistilianou M, Gougoustamou D, Athanassiadou F, Kotsis A, Catriu D. Adenosine deaminase activity and isozyme levels in serum and peripheral blood lymphocytes in childhood acute lymphoblastic leukemia. Mol Immunol. 1998;35(11-12):754-759
7. Petrola V, Toikka P, Irjala K, Mertsola J, Ruuskanen O. Discrepancy between total white blood cell count and serum C-reactive protein levels in febrile children. Scand J Infect Dis. 2007;39(6):560-565
8. Kalio R, Bloigu A, Surcel HM, Syrjiada H. C-reactive protein and erythrocyte sedimentation rate in differential diagnosis between infections and neoplastic fever in patients with solid tumours and lymphomas. Support Care Cancer. 2001;9:124-129
9. Hartel C, Deutser M, Lehrnbecher T, Schultz C. Current approaches for risk stratification of infectious complications in pediatric oncology. Pediatr Blood Cancer. 2007;49(6):767-773
10. Sheu JN, Chen MC, Lue KH, Sl Cheng, Lee IC, Chen SM, et al. Serum and urine levels of interleukin-6 and interleukin-8 in children with acute pyelonephritis. Cytokine. 2006;36(5-6):276-282
11. Shereen Mohamed EM, Manar Mohamed M, Manar Mohamed I, Lobna M, Hadir A. The diagnostic value of C-reactive protein, interleukin-8, and monocyte chemotactic protein in risk stratification of febrile neutropenic children with hematologic malignancies. J Pediatr Hematol Oncol. 2007;29(3):131-136
12. Lehrnbecher T, Venzon D, de Haas M, Chanock SJ, Kuel J. Assessment of measuring circulating levels of interleukin-6, interleukin-8, C-reactive protein, soluble Fc gamma receptor type III, and mannose-binding protein in febrile children with cancer and neutropenia. Clin Infect Dis. 1999;29:414-419
13. Nijsten MW, Olinga P, The TH, de Vries EG, Koops HS. Procalcitonin behaves as a fast responding acute phase protein in vivo and in vitro. Crit Care Med. 2000;28:458-461
14. Hoffmann G, Schobersberger W. Procalcitonin as a marker. Acta Anaesthesiol Scand. 2003;47(2):237-243
15. Gendel D, Bohuon C. Procalcitonin a marker of bacterial infection. Infection. 1997;25:133-138
16. Whang KT, Steinwald PM, White JC. Serum calcitonin precursors in sepsis and systemic inflammation. J Clin Endocrinol Metab. 1998;83:3296-3301
17. Emporiadou M, Hatzistilianou M, Haidopoulou K, Aggouridaki C, Reklity A, Magnisali C, et al. Procalcitonin and inflammatory cytokines in children with asthma. Eur J Inflamm. 2005;3(2):75-81.
18. Bernard L, Ferriere F, Casassus P, Malas E, Leveque S, Gu-illevin L. Procalcitonin as an early marker of bacterial infection in severely neutropenic febrile adults. Clin Infect Dis. 1998;27:914-917
19. Hatzistilianou M, Hitoglou S, Gougoustamou D, Rekliti A, Tzouvelekis G, Nanas C, et al. Serum procalcitonin, adenosine deaminase and its isoenzymes in the aetiological diagnosis of pneumonia in children. Int J Immunopathol Pharmacol. 2002;15(2):119-123
20. The Immunocompromised Host Society. The design, analysis, and reporting of clinical trials on the empirical antibiotic management of the neutropenic patient. J Infect Dis. 1990;161:397-404.
21. Alexander SW, Pizzo PA. Current considerations in the management of fever and neutropenia. In: Remington JS, Swartz MN, editors. Current clinical topics in infectious diseases. Oxford: Blackwell; 1999. p. 160-180
22. Hughes WT, Armstrong D, Bodey GP, Brown AE, Edwards JE, Feld R, et al. Guidelines for the use of antimicrobial agents in neutropenic patients with unexplained fever. Clin Infect Dis. 1997;25:551-555
23. Penel N, Fournier C, Clisant S, N'Guyen M. Causes of fever and value of C-reactive protein and procalcitonin in differentiating infections from paraneoplastic fever. Support Care Cancer. 2004;12:593-597
24. Ruokonen E, Nousiainen T, Pulkki K, Takala J. Procalcitonin concentrations in patients with neutropenic fever. Eur J Clin Microbiol Infect Dis. 1999;18:283-288
25. Schuttrump S, Binder L, Hagemann T, Berkovie D, Trumper L, Binder C. Procalcitonin: a useful discriminator between febrile conditions of different origin in hemato-oncological patients? Ann Hematol. 2003;82:98-101.
26. Hitoglou S, Hatzistilianou M, Gougoustamou D, Rekliti A, Agguridaki Ch, Athanassiadou F, et al. Serum adenosine deam-inase and procalcitonin concentrations in neutropenic febrile children with acute lymphoblastic leukemia. Clin Exp Med. 2005;5:60-65
27. Christ-Crain M, Jaccard-Stolz D, Bingisser R, Gencay M, Huber P, Tamm M, et al. Effect of procalcitonin-guided treatment on antibiotic use and outcome in lower respiratory tract infections: cluster-randomised, single-blinded intervention trial. Lancet. 2004;363:600-605
28. Hatzistilianou M, Rekleity A, Athanassiadou F, Delutils MA, Conti P, Catriu D. Serial procalcitonin responses in infection of children with secondary immunodeficiency. Clin Invest Med. 2007;30(2):75-85.
29. Mitaka C. Clinical laboratory differentiation of infectious versus non-infectious systemic inflammatory response syndrome. Clin Chim Acta. 2005;351(1-2):17-21.
30. Chesney J, Metz C, Stavitsky AB, Bacher M, Bacher R. Regulated production of type I collagen and inflammatory cytokines by peripheral blood fibrocytes. J Immunol. 1998; 160:419-25
31. Harbarth S, Holechova K, Froidevaux C, Pittet D, Ricou B, Grau G, et al. Diagnostic value of procalcitonin, interleukin-6 and interleukin-8 in critically III patients admitted with suspected sepsis. J Resp Crit Care Med. 2001;164(3):396-402.
32. Fleischhack G, Kambeck I, Cipic D, Hasan C, Bode U. Pro-calcitonin in paediatric cancer patients: its diagnostic relevance is superior to that of C-reactive protein, interleukin 6, interleukin 8, soluble interleukin 2 receptor and soluble necrosis factor receptor II. Br J Haematol. 2000;111:1093-1102